Negotiated Compliance Deal

Shkreli may settle to avoid discovery, additional sanctions, or a broader contempt ruling. A negotiated order would likely preserve the lifetime ban while adding compliance mechanics rather than altering pharmaceutical regulation more broadly.

Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.